Giovanni Scambia

Summary

Affiliation: Catholic University
Country: Italy

Publications

  1. pmc Indoleamine 2,3-dioxygenase 1 (IDO1) activity correlates with immune system abnormalities in multiple myeloma
    Giuseppina Bonanno
    Department of Gynecology, Catholic University Med School, Rome, Italy
    J Transl Med 10:247. 2012
  2. pmc Long-term prospective longitudinal evaluation of emotional distress and quality of life in cervical cancer patients who remained disease-free 2-years from diagnosis
    Giovanna Mantegna
    Psycho Oncology Service, Catholic University, Campobasso, Italy
    BMC Cancer 13:127. 2013
  3. pmc MiR-200c and HuR in ovarian cancer
    Silvia Prislei
    Laboratory of Antineoplastic Pharmacology, Department of Obstetrics and Gynecology, Catholic University of the Sacred Heart, Rome 00168, Italy
    BMC Cancer 13:72. 2013
  4. pmc Conservatively treated glassy cell carcinoma of the cervix
    Gabriella Ferrandina
    Department of Oncology, Catholic University, Campobasso, Rome, Italy
    World J Surg Oncol 6:92. 2008
  5. pmc Thymoglobulin, interferon-γ and interleukin-2 efficiently expand cytokine-induced killer (CIK) cells in clinical-grade cultures
    Giuseppina Bonanno
    Department of Gynecology, Catholic University Med School, and Department of Blood Transfusion and Cell Therapy, Azienda Ospedaliera S Camillo Forlanini, Rome, Italy
    J Transl Med 8:129. 2010
  6. pmc Effects of pegylated G-CSF on immune cell number and function in patients with gynecological malignancies
    Giuseppina Bonanno
    Department of Hematology, Catholic University Med, School, Rome, Italy
    J Transl Med 8:114. 2010
  7. pmc Solitary pancreatic lymph node metastasis from carcinoma of the breast: case report
    Giacomo Corrado
    Gynecologic Oncology Unit, Department of Oncology, Catholic University of the Sacred Heart, L, go A, Gemelli, 1 86100, Campobasso Italy
    Diagn Pathol 5:29. 2010
  8. pmc Interleukin-21 induces the differentiation of human umbilical cord blood CD34-lineage- cells into pseudomature lytic NK cells
    Giuseppina Bonanno
    Department of Gynaecology, Catholic University Medical School, Rome, Italy
    BMC Immunol 10:46. 2009
  9. pmc Phase II study of the combination carboplatin plus celecoxib in heavily pre-treated recurrent ovarian cancer patients
    Francesco Legge
    Gynecologic Oncology Unit, Catholic University of Campobasso, Italy
    BMC Cancer 11:214. 2011
  10. pmc CD133 antigen expression in ovarian cancer
    Gabriella Ferrandina
    Gynecologic Oncology Unit, Department of Oncology, Catholic University, Campobasso, Italy
    BMC Cancer 9:221. 2009

Detail Information

Publications14

  1. pmc Indoleamine 2,3-dioxygenase 1 (IDO1) activity correlates with immune system abnormalities in multiple myeloma
    Giuseppina Bonanno
    Department of Gynecology, Catholic University Med School, Rome, Italy
    J Transl Med 10:247. 2012
    ..It is presently unknown whether MM cells express IDO1 and whether IDO1 activity correlates with immune system impairment...
  2. pmc Long-term prospective longitudinal evaluation of emotional distress and quality of life in cervical cancer patients who remained disease-free 2-years from diagnosis
    Giovanna Mantegna
    Psycho Oncology Service, Catholic University, Campobasso, Italy
    BMC Cancer 13:127. 2013
    ..Here, we provide the first 2-years prospective, longitudinal study evaluating emotional distress and QoL in early stage (ECC) and locally advanced (LACC) cervical cancer patients who remained disease-free 2-years from diagnosis...
  3. pmc MiR-200c and HuR in ovarian cancer
    Silvia Prislei
    Laboratory of Antineoplastic Pharmacology, Department of Obstetrics and Gynecology, Catholic University of the Sacred Heart, Rome 00168, Italy
    BMC Cancer 13:72. 2013
    ..This study assessed the role of miR-200c as regulator of class III β-tubulin (TUBB3), a factor associated with drug-resistance and poor prognosis in ovarian cancer...
  4. pmc Conservatively treated glassy cell carcinoma of the cervix
    Gabriella Ferrandina
    Department of Oncology, Catholic University, Campobasso, Rome, Italy
    World J Surg Oncol 6:92. 2008
    ..Very little data about the conservative treatment of early stage glassy cell cervical cancer have been reported...
  5. pmc Thymoglobulin, interferon-γ and interleukin-2 efficiently expand cytokine-induced killer (CIK) cells in clinical-grade cultures
    Giuseppina Bonanno
    Department of Gynecology, Catholic University Med School, and Department of Blood Transfusion and Cell Therapy, Azienda Ospedaliera S Camillo Forlanini, Rome, Italy
    J Transl Med 8:129. 2010
    ....
  6. pmc Effects of pegylated G-CSF on immune cell number and function in patients with gynecological malignancies
    Giuseppina Bonanno
    Department of Hematology, Catholic University Med, School, Rome, Italy
    J Transl Med 8:114. 2010
    ....
  7. pmc Solitary pancreatic lymph node metastasis from carcinoma of the breast: case report
    Giacomo Corrado
    Gynecologic Oncology Unit, Department of Oncology, Catholic University of the Sacred Heart, L, go A, Gemelli, 1 86100, Campobasso Italy
    Diagn Pathol 5:29. 2010
    ..We report the first case of isolated pancreatic lymph node recurrence in a locally advanced breast cancer patient...
  8. pmc Interleukin-21 induces the differentiation of human umbilical cord blood CD34-lineage- cells into pseudomature lytic NK cells
    Giuseppina Bonanno
    Department of Gynaecology, Catholic University Medical School, Rome, Italy
    BMC Immunol 10:46. 2009
    ..The present study was designed and conducted to address whether IL-21 might replace the stromal cell requirements and foster the IL-15-induced NK differentiation of human UCB CD34-lineage- cells...
  9. pmc Phase II study of the combination carboplatin plus celecoxib in heavily pre-treated recurrent ovarian cancer patients
    Francesco Legge
    Gynecologic Oncology Unit, Catholic University of Campobasso, Italy
    BMC Cancer 11:214. 2011
    ..We evaluated the antitumor activity and safety of the combination carboplatin plus the COX-2 inhibitor celecoxib in recurrent heavily-treated OC patients...
  10. pmc CD133 antigen expression in ovarian cancer
    Gabriella Ferrandina
    Gynecologic Oncology Unit, Department of Oncology, Catholic University, Campobasso, Italy
    BMC Cancer 9:221. 2009
    ..The aim of the study was to investigate the clinical role of the immunohistochemically assessed expression of CD133 in a large single Institution series of ovarian cancer patients...
  11. pmc Safety of a 3-weekly schedule of carboplatin plus pegylated liposomal doxorubicin as first line chemotherapy in patients with ovarian cancer: preliminary results of the MITO-2 randomized trial
    Sandro Pignata
    Medical Oncology B, National Cancer Institute, Naples, Italy
    BMC Cancer 6:202. 2006
    ..Due to the paucity of published phase I data on the 3-weekly experimental schedule used, an early safety analysis was planned...
  12. pmc Epithelial ovarian cancer relapsing as isolated lymph node disease: natural history and clinical outcome
    Francesco Legge
    Gynecologic Oncology Unit, Department of Oncology, Catholic University of Campobasso, Italy
    BMC Cancer 8:367. 2008
    ..The aim of the study was to retrospectively review ILNR observed in our Institution over the past 11 years in order to investigate: the pattern of disease progression after the first diagnosis of ILNR, and their clinical outcome...
  13. pmc Residual neurotoxicity in ovarian cancer patients in clinical remission after first-line chemotherapy with carboplatin and paclitaxel: the Multicenter Italian Trial in Ovarian cancer (MITO-4) retrospective study
    Sandro Pignata
    Medical Oncology B, National Cancer Institute, Naples, Italy
    BMC Cancer 6:5. 2006
    ..We retrospectively assessed the prevalence of residual neuropathy in a cohort of patients in clinical remission after first-line carboplatin/paclitaxel for advanced ovarian cancer...